itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Alibaba Researchers Introduce R1-Omni: An Application of Reinforcement Learning with Verifiable Reward (RLVR) to an Omni-Multimodal Large Language Model

    13 марта, 2025

    Emotion recognition from video involves many nuanced challenges. Models that depend exclusively on either visual or audio signals often miss the intricate interplay between these modalities, leading to misinterpretations of emotional content. A key difficulty is reliably combining visual cues—such as facial expressions or body language—with auditory signals like tone or intonation. Many existing systems… →

    AI News
  • From Sparse Rewards to Precise Mastery: How DEMO3 is Revolutionizing Robotic Manipulation

    13 марта, 2025

    Long-horizon robotic manipulation tasks are a serious challenge for reinforcement learning, caused mainly by sparse rewards, high-dimensional action-state spaces, and the challenge of designing useful reward functions. Conventional reinforcement learning is not well-suited to handle efficient exploration since the lack of feedback hinders learning optimal policies. This issue is significant in robotic control tasks of… →

    AI News
  • Building an Interactive Bilingual (Arabic and English) Chat Interface with Open Source Meraj-Mini by Arcee AI: Leveraging GPU Acceleration, PyTorch, Transformers, Accelerate, BitsAndBytes, and Gradio

    12 марта, 2025

    In this tutorial, we implement a Bilingual Chat Assistant powered by Arcee’s Meraj-Mini model, which is deployed seamlessly on Google Colab using T4 GPU. This tutorial showcases the capabilities of open-source language models while providing a practical, hands-on experience in deploying state-of-the-art AI solutions within the constraints of free cloud resources. We’ll utilise a powerful… →

    AI News
  • This AI Paper Introduces R1-Searcher: A Reinforcement Learning-Based Framework for Enhancing LLM Search Capabilities

    12 марта, 2025

    Large language models (LLMs) models primarily depend on their internal knowledge, which can be inadequate when handling real-time or knowledge-intensive questions. This limitation often leads to inaccurate responses or hallucinations, making it essential to enhance LLMs with external search capabilities. By leveraging reinforcement learning, researchers are actively working on methods to improve these models’ ability… →

    AI News
  • HybridNorm: A Hybrid Normalization Strategy Combining Pre-Norm and Post-Norm Strengths in Transformer Architectures

    12 марта, 2025

    Transformers have revolutionized natural language processing as the foundation of large language models (LLMs), excelling in modeling long-range dependencies through self-attention mechanisms. However, as these models grow deeper and more complex, training stability presents a significant challenge that directly impacts performance. Researchers face a troublesome trade-off between two primary normalization strategies: Pre-Layer Normalization (Pre-Norm) and… →

    AI News
  • Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma

    12 марта, 2025

    CONCLUSIONS: Intensive therapy based on a high cytarabine dose and continuously administered EDOCH achieved a high MRD-negative rate and provides an optional induction choice for young patients with MCL with high-risk factors. →

    Clinical Trials
  • Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial

    12 марта, 2025

    BACKGROUND: Gastric cancer (GC) is one of the most prevalent malignant tumors worldwide, often diagnosed at an advanced stage with a poor prognosis. Paclitaxel, nab-paclitaxel, and irinotecan, either as monotherapies or in combination with ramucirumab, are currently standard second-line treatments for GC. However, the efficacy of these therapies is limited, necessitating the development of new… →

    Clinical Trials
  • Causes and impacts of interrupted enteral nutrition in critically ill patients: A secondary analysis of a cluster-randomized controlled trial

    12 марта, 2025

    CONCLUSIONS: Based on this multicentre study about ENI, the incidence of interruptions in enteral nutrition was 18.6%, with diagnostic and therapeutic procedures being the leading causes. The occurrence of interruptions in the delivery of enteral nutrition leads to a reduction in the nutritional intake of critically ill patients. →

    Clinical Trials
  • Comparing HemoCue® and Quantitative Buffy Coat® and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis

    12 марта, 2025

    CONCLUSIONS: Compared to Coulter and QBC®, mean HemoCue® measured Hb concentrations were lower and, compared to the Coulter or QBC® methods, had an overall tendency to measure lower Hb concentrations with increasing Hb concentrations. Upper and lower limits of agreement were wider than the predefined clinically acceptable limits of ± 0.5 g/dL. HemoCue® should be… →

    Clinical Trials
  • Evaluating the efficacy of N-acetylcysteine in diminishing the duration and frequency of rotavirus-induced gastroenteritis: a preliminary randomized, placebo-controlled, double-blind clinical trial

    12 марта, 2025

    CONCLUSIONS: Even though the effects of NAC were observed in lowering the duration of the period and decreasing the frequency of bowel movements in gastroenteritis, these results did not reach statistical significance. Hence, the data from this study suggest that NAC may not effectively reduce the duration of diarrhea and the frequency of bowel movements… →

    Clinical Trials
Предыдущая страница
1 … 462 463 464 465 466 … 978
Следующая страница